

Biodesix shares fall after hours following third-quarter results and revised 2026 revenue guidance.
You can purchase shares of Biodesix (NASDAQ:BDSX) through any online brokerage.
Other companies in Biodesix’s space includes: CVS Health Corp (NYSE:CVS), The Cigna Group (NYSE:CI), Labcorp Holdings Inc (NYSE:LH), Quest Diagnostics Inc (NYSE:DGX) and Guardant Health Inc (NASDAQ:GH).
Biodesix has a consensus price target of $38.13.
The stock price for Biodesix (NASDAQ: BDSX) is $9 last updated November 6, 2026 at 7:55 PM EST.
There are no upcoming dividends for Biodesix.
Biodesix does not have any upcoming earnings scheduled.
There is no upcoming split for Biodesix.
Biodesix is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include...